Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. , Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, Augustine AH, Augustine EU, Aminoff MJ, Bodis-Wollner IG, Boyd J, Cambi F, Chou K, Christine CW, Cines M, Dahodwala N, Derwent L, Dewey RB, Hawthorne K, Houghton DJ, Kamp C, Leehey M, Lew MF, Liang GS, Luo ST, Mari Z, Morgan JC, Parashos S, Pérez A, Petrovitch H, Rajan S, Reichwein S, Roth JT, Schneider JS, Shannon KM, Simon DK, Simuni T, Singer C, Sudarsky L, Tanner CM, Umeh CC, Williams K, Wills AM JAMA 2015 Feb 10 313(6):584-93.
Patient feedback information is available for physicians employed by Rush University Medical Center who have received
30 or more patient surveys. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Friendliness/courtesy of the care provider
Explanations the care provider gave you about your problem or condition
Concern the care provider showed for your questions or worries
Likelihood of your recommending this care provider to others
Care provider's efforts to include you in decisions about your treatment
Information the care provider gave you about medications
Instructions the care provider gave you about follow-up care
Your confidence in this care provider
Degree to which care provider talked with you using words you could understand
Amount of time the care provider spent with you
For more information about patient feedback, see the Quality Care section of the Rush University Medical Center website.
(If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
To be able to offer people a better quality of life — despite the neurological disease — that’s what rings my bell. I mean that was really, for me, what made me want to go into neurology, and specifically into these degenerative diseases like Parkinson’s disease and Huntington’s disease.
Diagnoses are made based on history and physical examination, which is the old-fashioned kind of medicine. There was a time when that was the only way diagnoses were made. And even though there are a lot of interesting technologies, in my area of neurology, we make all of our diagnoses based on listening to the patient and examining that patient.
It’s wonderfully appealing to be able to sit down with someone, listen to their story, and then figure out what’s wrong with them, tell them about that diagnosis, educate them about their diagnosis, and work together for a plan.
Because neurology has had so few effective treatments for so long, it’s a very explosive field now. It looks like we’re going to have a lot of big breakthroughs in our area in just the next decade or so. This has happened in other areas of neurology — like multiple sclerosis has had a lot of big breakthroughs. But for us, I think we’re on the threshold of some really big science that’s going to affect our patients’ lives everyday.